Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Engineered T-cells that express both CARs and TCRs can better distinguish between cancerous and healthy tissues

    7 hours ago

    Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.
    Click here to Read more
    Prev Article
    The biggest geomagnetic storm in 20 years: NASA's lessons and surprises
    Next Article
    New mathematical approach transforms simulations of large molecule behavior

    Related Science Updates:

    Comments (0)

      Leave a Comment